FDA-approved GLP-1 weight loss medications available at Vitercure Wegovy (semaglutide 2.4mg weekly) for chronic weight management Zepbound (tirzepatide weekly) for chronic weight management and sleep apnea Ozempic (semaglutide weekly) for type 2 diabetes management Mounjaro (tirzepatide weekly) for type 2 diabetes management Saxenda (liraglutide 3mg daily) for chronic weight management Rybelsus (oral semaglutide) for type 2 diabetes management Trulicity (dulaglutide weekly) for type 2 diabetes management For a head-to-head comparison, see our guide on Wegovy vs Zepbound vs Mounjaro vs Saxenda
If you would like to discuss your weight loss goals and options, please call our office to make an appointment.
B12 adequacy is directly relevant here since B12 deficiency independently causes cognitive symptoms and mood disturbance, which is another reason the B12-containing formulation is preferred for long-term use
Great product and customer service
However, Mounjaro targets both GLP-1 and GIP receptors, making it a dual-action medication that may offer greater appetite suppression and improved metabolism for some patients
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 15, 155163
